[女性性欲减退障碍中的睾酮治疗]

[Testosterone therapy in female hypoactive sexual desire disorder].

作者信息

Meyer Patrick

出版信息

Rev Med Suisse. 2016 Mar 16;12(510):540-3.

Abstract

Hypoactive sexual desire disorder (HSDD) is a deficiency of sexual desire that causes marked personal or interpersonal distress. It occurs in approximately 1 in 10 adult women. A number of potential contributory factors (hormonal, neurobiological and psychosocial) have been identified. Testosterone plays an excitatory role in sexual desire but the mechanism is not yet well understood. Treatment with testosterone has been shown to improve sexual desire in menopausal women with HSDD. However, there are limited data concerning premenopausal women and long-term safety. At present, physiological testosterone preparations for use in women are not available in Switzerland.

摘要

性欲减退障碍（HSDD）是一种性欲缺乏，会导致明显的个人困扰或人际关系困扰。约每10名成年女性中就有1人会出现这种情况。已经确定了一些潜在的促成因素（激素、神经生物学和心理社会因素）。睾酮在性欲方面起兴奋作用，但其机制尚未完全明确。已证明用睾酮治疗可改善患有HSDD的绝经后女性的性欲。然而，关于绝经前女性和长期安全性的数据有限。目前，瑞士没有可供女性使用的生理性睾酮制剂。